Clinical trial

A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA

NCT00006430

StatusUNKNOWN

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE1

Study timeline

Registry last updated2005-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Autologous dendritic cells transfected with amplified tumor RNABIOLOGICAL

Sponsors & collaborators

National Center for Research Resources (NCRR)lead sponsor

Duke Universitycollaborator

Mapped research locations

DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00006430 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.